CGNX stock Cognex (NASDAQ) $37.37 intraday 09 Jan 2026: AI vision demand supports analyst targets

CGNX stock Cognex (NASDAQ) $37.37 intraday 09 Jan 2026: AI vision demand supports analyst targets

CGNX stock trades at $37.37 intraday on the NASDAQ in the United States on 09 Jan 2026, down 1.46% today as investors balance stronger AI-driven machine vision demand against a premium multiple. Cognex Corporation (CGNX) shows PE 58.06, market cap $6.33B, and volume 1,486,501 versus a 50-day average of 38.23. We focus on near-term earnings, analyst price targets and AI tailwinds that could move the stock ahead of the next report and provide actionable checkpoints for intraday traders and longer-term AI stock investors.

Intraday price action and quick CGNX stock snapshot

Cognex Corporation (CGNX) is trading on NASDAQ at $37.37 with a day low of $37.10 and day high of $38.11. Volume is 1,486,501, below the 3-month average of 1,836,217, giving today a muted headline move. The stock sits between its 50-day average $38.23 and 200-day average $36.46, making the $36.46 area a visible technical support. Traders should note today’s intraday range and relative volume before scaling in or out for AI-theme exposure.

Earnings, revenue trends and CGNX earnings outlook

Recent quarterly results show mixed signs for CGNX earnings. The company reported EPS $0.25 and revenue $249,093,000 on 30 July 2025, beating some estimates. Earlier in April 2025 EPS was $0.16 with revenue $216,036,000, reflecting sequential recovery. Analysts estimate revenue around $261,886,640 for the 29 Sep 2025 fiscal quarter and EPS estimate $0.27 for the 29 Sep 2025 period. The next confirmed earnings announcement date is 2026-02-12, making near-term guidance and AI-related bookings the key catalysts for the CGNX stock move.

CGNX stock valuation and financial metrics

Cognex trades at a premium with PE 58.06, price-to-sales 6.50, and price-to-book 4.24 on a trailing basis. Revenue per share TTM is 5.79 and free cash flow per share TTM is 1.27, with a free cash flow yield near 3.39%. The company carries low net debt and a strong current ratio 3.96, supporting balance-sheet stability. These ratios underline why analysts split between growth appreciation and valuation risk when sizing CGNX stock in AI hardware portfolios.

CGNX stock technicals and intraday trading levels

Short-term indicators are mixed for CGNX stock. RSI sits at 52.20 and MACD histogram reads 0.32, signaling neutral momentum. Bollinger Bands show an upper band at 38.45 and lower band at 35.01, so $38.45 acts as immediate resistance and $35.01–$36.46 as a support band. Average true range is 1.06, suggesting a normal intraday swing around one dollar. For intraday traders, a break above $38.45 on rising volume opens the analyst consensus targets; a failure below $36.46 increases downside pressure.

Meyka AI grade, analyst targets and CGNX forecast

Meyka AI, an AI-powered market analysis platform, rates CGNX with a score out of 100: 78.01 | Grade B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Consensus price targets show a mean $48.45, median $50.00, high $58.00 and low $38.00. The median target implies +33.77% upside from $37.37.

Meyka AI’s forecast model projects a monthly target of $41.41 (+10.85% vs current price), a quarterly level $35.60 (‑4.76%), and a 12‑month projection $28.58 (‑23.49%). Forecasts are model-based projections and not guarantees. Company filings and investor updates are here and current market quotes are available on Nasdaq’s CGNX page.

Risks, catalysts and a clear CGNX investment checklist

Key catalysts include AI-related machine vision orders, automotive factory restarts, and stronger barcode reader demand. Near-term risk centers on the high valuation, slower industrial capex, and inventory cycles. Watch gross margin trends, backlog commentary at earnings, and adoption of Cognex deep learning tools. For portfolio managers, treat CGNX stock as a growth-exposed AI hardware play and size positions against valuation and liquidity: current float supports tactical entries but keep stop-loss discipline near $36.46.

Final Thoughts

CGNX stock offers direct AI vision exposure through Cognex Corporation on the NASDAQ in the United States. At $37.37 intraday, the stock sits between near-term support at the 200-day average $36.46 and resistance near the Bollinger upper band $38.45. Analyst consensus leans bullish with a median price target $50.00 implying +33.77% upside, while Meyka AI’s model gives a near-term monthly projection of $41.41 (+10.85%) and a 12‑month projection of $28.58 (‑23.49%). Our proprietary Meyka AI grade rates CGNX B+ (78.01) and factors in sector, growth, and analyst inputs. Investors focused on AI stocks should watch upcoming earnings on 2026-02-12, revenue bookings, and margin commentary. Forecasts are model-based projections and not guarantees. Use position sizing and clear exit levels when adding CGNX stock to AI or automation allocations.

FAQs

What is the current CGNX stock price and market cap?

CGNX stock trades at $37.37 intraday on NASDAQ with a market cap of approximately $6.33B and volume about 1,486,501 shares today in the United States market.

What are the analyst price targets and upside for CGNX stock?

Analyst consensus target averages $48.45 with a median $50.00, implying roughly +29.67% to the mean and +33.77% to the median from the current $37.37 price.

How does Meyka AI rate CGNX and what are the forecasts?

Meyka AI rates CGNX 78.01 out of 100, Grade B+ (Suggestion: BUY). Meyka AI’s forecast model projects monthly $41.41 (+10.85%) and 12‑month $28.58 (‑23.49%). Forecasts are projections, not guarantees.

What are the main risks for CGNX stock?

Primary risks for CGNX stock include a high PE 58.06, inventory cycles in industrial clients, slower capex, and margin pressure. Watch earnings updates and booking commentary for AI vision demand signals.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *